AIG
GBT

American International Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

American International Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,664
Closed -$2.09M – 3054
2022
Q3 		$2.09M Buy
30,664
+1,494
+5% +$82.4K 0.02% 927
2022
Q2 		$932K Sell
29,170
-1,585
-5% -$46.4K 0.01% 1243
2022
Q1 		$1.06M Sell
30,755
-2,164
-7% -$64.7K 0.01% 1296
2021
Q4 		$964K Buy
32,919
+161
+0.5% +$4.99K ﹤0.01% 1456
2021
Q3 		$835K Sell
32,758
-778
-2% -$22.9K ﹤0.01% 1534
2021
Q2 		$1.17M Buy
33,536
+32,205
+2,420% +$1.26M ﹤0.01% 1427
2021
Q1 		$54K Sell
1,331
-159
-11% -$7.31K ﹤0.01% 2966
2020
Q4 		$65K Sell
1,490
-41
-3% -$2.02K ﹤0.01% 2869
2020
Q3 		$84K Sell
1,531
-70
-4% -$4.45K ﹤0.01% 2624
2020
Q2 		$101K Sell
1,601
-32,692
-95% -$2.24M ﹤0.01% 2537
2020
Q1 		$1.75M Sell
34,293
-1,982
-5% -$133K 0.01% 922
2019
Q4 		$2.88M Sell
36,275
-305
-0.8% -$18.1K 0.01% 899
2019
Q3 		$1.77M Buy
36,580
+1,961
+6% +$102K 0.01% 1024
2019
Q2 		$1.82M Buy
34,619
+479
+1% +$27.5K 0.01% 1039
2019
Q1 		$1.81M Buy
34,140
+1,243
+4% +$61.1K 0.01% 1035
2018
Q4 		$1.35M Sell
32,897
-252
-0.8% -$9.44K 0.01% 1119
2018
Q3 		$1.26M Buy
33,149
+598
+2% +$26.5K ﹤0.01% 1292
2018
Q2 		$1.47M Buy
32,551
+7,654
+31% +$349K 0.01% 1154
2018
Q1 		$1.2M Buy
24,897
+28
+0.1% +$1.56K ﹤0.01% 1168
2017
Q4 		$979K Buy
24,869
+117
+0.5% +$4.37K ﹤0.01% 1384
2017
Q3 		$769K Buy
24,752
+1,850
+8% +$52K ﹤0.01% 1509
2017
Q2 		$626K Buy
22,902
+12,871
+128% +$383K ﹤0.01% 1548
2017
Q1 		$370K Buy
10,031
+1,945
+24% +$49K ﹤0.01% 1810
2016
Q4 		$117K Sell
8,086
-22
-0.3% -$387 ﹤0.01% 2511
2016
Q3 		$187K Buy
8,108
+12
+0.1% +$229 ﹤0.01% 2213
2016
Q2 		$134K Buy
8,096
+4,131
+104% +$83.3K ﹤0.01% 2402
2016
Q1 		$63K Buy
+3,965
New +$70.5K ﹤0.01% 3742

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

American International Group's GBT Position: Q4 2022 in Review

American International Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 30,664 shares — an estimated $2.09M sold.

American International Group first reported a position in GBT in Q1 2016 and held it in 27 quarters. The position peaked at $2.88M in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • American International Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • American International Group sold 30,664 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $2.09M.
  • American International Group first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 27 quarters.
  • American International Group's Global Blood Therapeutics, Inc. position peaked at $2.88M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on American International Group's 13F filing for Q4 2022, filed 10 Feb 2023.